0001104659-24-066783.txt : 20240530 0001104659-24-066783.hdr.sgml : 20240530 20240530195154 ACCESSION NUMBER: 0001104659-24-066783 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240521 FILED AS OF DATE: 20240530 DATE AS OF CHANGE: 20240530 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chole Timothy CENTRAL INDEX KEY: 0002025169 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23661 FILM NUMBER: 241007210 MAIL ADDRESS: STREET 1: 851 DUPORTAIL ROAD STREET 2: 2ND FLOOR CITY: CHESTERBROOK STATE: PA ZIP: 19087 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ROCKWELL MEDICAL, INC. CENTRAL INDEX KEY: 0001041024 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 383317208 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 30142 WIXOM ROAD CITY: WIXOM STATE: MI ZIP: 48393 BUSINESS PHONE: 8004493353 MAIL ADDRESS: STREET 1: 30142 WIXOM ROAD CITY: WIXOM STATE: MI ZIP: 48393 FORMER COMPANY: FORMER CONFORMED NAME: ROCKWELL MEDICAL TECHNOLOGIES INC DATE OF NAME CHANGE: 20120530 FORMER COMPANY: FORMER CONFORMED NAME: ROCKWELL MEDICAL, INC. DATE OF NAME CHANGE: 20120525 FORMER COMPANY: FORMER CONFORMED NAME: ROCKWELL MEDICAL TECHNOLOGIES INC DATE OF NAME CHANGE: 19970722 3 1 tm2416038-1_3seq1.xml OWNERSHIP DOCUMENT X0206 3 2024-05-21 0 0001041024 ROCKWELL MEDICAL, INC. RMTI 0002025169 Chole Timothy C/O ROCKWELL MEDICAL, INC. 30142 WIXOM ROAD WIXOM MI 48393 0 1 0 0 SVP, CHIEF COMMERCIAL OFFICER Common Stock 33330 D Common Stock 25665 D Non-Qualified Stock Options 24.20 2029-12-16 Common Stock 4545 D Non-Qualified Stock Options 22.44 2030-06-11 Common Stock 13636 D Non-Qualified Stock Options 10.38 2031-05-03 Common Stock 13636 D Non-Qualified Stock Options 1.66 2032-09-09 Common Stock 60000 D Non-Qualified Stock Options 1.37 2033-03-17 Common Stock 32990 D Non-Qualified Stock Options 1.39 2034-03-14 Common Stock 47190 D Restricted stock units fully vest on March 14, 2027, subject to the Reporting Person's continued service to the Issuer. Restricted stock units fully vest on March 17, 2025, subject to the Reporting Person's continued service to the Issuer. Includes 12,832 shares of unvested common stock. Stock options vested in three equal installments on the first, second and third anniversaries of December 16, 2019. Stock options vested in three equal installments on the first, second and third anniversaries of June 11, 2020. Stock options vest in two equal installments on the second and fourth anniversaries of May 3, 2021, subject to the Reporting Person's continued service to the Issuer. Stock options vest in four equal installments on the first, second, third and fourth anniversaries of September 9, 2022, subject to the Reporting Person's continued service to the Issuer. Stock options vest 25% on the first anniversary of March 17, 2023, with the remainder vesting in equal monthly installments through March 17, 2027, subject to the Reporting Person's continued service to the Issuer. Stock options vest 25% on the first anniversary of March 14, 2024, with the remainder vesting in equal monthly installments through March 17, 2027, subject to the Reporting Person's continued service to the Issuer. Ex. 24 - Power of Attorney /s/ Megan Timmins, Attorney-in-Fact for Timothy Chole 2024-05-30 EX-24 2 tm2416038d1_ex24.htm EXHIBIT 24

Exhibit 24

POWER OF ATTORNEY

Know all by these presents, that, for good and valuable consideration, the sufficiency and receipt of which are hereby acknowledged, the undersigned hereby constitutes and appoints each of Mark Strobeck, Ph.D., Megan Timmins and Ryan Murr, and any of their substitutes, signing singly, the undersigned's true and lawful attorney-in-fact to:

(1) execute for and on behalf of the undersigned (in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules thereunder (the "Exchange Act")), any and all Forms 3, 4 and/or 5, and any amendments thereto, that are necessary or advisable for the undersigned to file under Section 16( a) (collectively, "Documents") with respect to the undersigned's holdings of and transactions in the securities issued by Rockwell Medical, Inc., a Delaware corporation (the "Company").

(2) do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to complete and execute any such Documents and timely file such Documents with the United States Securities and Exchange Commission and any stock exchange or similar authority; and

(3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that each such attorney-in- fact ( or such attorney-in-fact's substitute or substitutes) shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that each attorney-in-fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is such attorney-in-fact's substitute or substitutes or the Company assuming, any of the undersigned's responsibilities to comply with the Exchange Act.

The undersigned agrees that such attorney-in-fact may rely entirely on information furnished orally or in writing by the undersigned to such attorney-in-fact. The undersigned also agrees to indemnify and hold harmless the Company and such attorney-in-fact against any losses, claims, damages or liabilities (or actions in these respects) that arise out of or are based on any untrue statement or omission of necessary facts in the information provided by the undersigned to such attorney-in-fact for purposes of executing, acknowledging, delivering and filing Documents and agrees to reimburse the Company and such attorney-in-fact for any legal or other expenses reasonably incurred in connection with investigating or defending against any such loss, claim, damage, liability or action.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Documents with respect to the undersigned' s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to each of the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 22nd day of May, 2024.

	/s/ Timothy Chole
	Name: Timothy Chole